Table 7 Studies describing hospital costs or charges in patients with resistant and multidrug-resistant Pseudomonas aeruginosa infections
Author | Study groups (n) | Description of cost | Hospital Inpatient Care Costs or Charges | Reported P-value | Ref |
|---|---|---|---|---|---|
Main findings | |||||
Eagye et al. (2009) | Meropenem resistant P. aeruginosa (58) | Median total cost (IQR) | $100,704 ($27,710 – $183,125) | < 0.001 | [53] |
Meropenem susceptible P. aeruginosa (125) | $32,594 ($13,112 – $100,702) | ||||
Meropenem resistant P. aeruginosa (58) | $100,704 ($27,710 – $183,125) | < 0.001 | |||
Control (57) | $25,744 ($17,456 – $40,616) | ||||
Evans et al. (2007) | Susceptible P. aeruginosa (73) | Median total cost (IQR) | $99,672 ($43,714 – $187,260 | 0.015 | [71] |
Resistant P. aeruginosaa (47) | $69,502 ($24,853 – $113,933) | ||||
Gasink et al. (2006) | Fluoroquinolone resistant P. aeruginosa (320) | Median total charges (IQR)* | $62,325 ($22,129 - $188,979) | 0.008 | [64] |
Fluoroquinolone susceptible P. aeruginosa (527) | $48,733 ($18,760 - $124,820) | ||||
Lautenbach et al. (2010) | Imipenem resistant P. aeruginosa (253) | Mean hospital cost after culture sampling (95% CI) | $286,417 ($234,326 – $338,510) | < 0.001 | [63] |
Imipenem susceptible P. aeruginosa (2289) | $189,274 ($172,428 – $206,121) | ||||
Morales et al. (2012) | MDR P. aeruginosab (134) | Mean hospital cost after culture sampling (median) | $13,178 ($5,745) | < 0.001†| [49] |
Susceptible P. aeruginosa (149) | $4,258 ($2,420) | ||||
Resistant P. aeruginosa (119) | $10,662 ($5,248) | < 0.001†| |||
Susceptible P. aeruginosa (149) | $4,258 ($2,420) |